Tzannes, S., M. F. Hammond, et al. (2008). "Owners 'perception of their cats' quality of life during COP chemotherapy for lymphoma." J Feline Med Surg 10(1): 73-81.
Lymphoma is one of the most common feline cancers and many owners opt for chemotherapy as a treatment option. Most owners are concerned about quality of life for feline cancer patients, both with and without chemotherapy. Questionnaires on quality of life (QOL) were completed by the owners of 31 cats undergoing treatment for lymphoma between 2002 and 2006. All cats were treated with cyclophosphamide, vincristine, and prednisolone (COP). QOL scores were significantly higher in cats before the onset of cancer than after, but before the start of chemotherapy. During chemotherapy, QOL scores were also lower than before the onset of cancer, but were significantly higher than prior to starting treatment. The majority of cats (87%) experienced adverse effects during treatment. Most pet owners (83%) were happy they treated their cats and most (87%) would treat another cat. The results of this questionnaire survey indicate that COP chemotherapy is well tolerated by cats according to owner perceptions of QOL.
>> PubMed abstract
Related articles:
Teske, E., G. van Straten, et al. (2002). "Chemotherapy with cyclophosphamide, vincristine, and prednisone (COP) in cats with malignant lymphoma: new results with an old protocol." J Vet Intern Med 16(2): 179-186.
>> PubMed abstract
More on cat health: Winn Feline Foundation
No comments:
Post a Comment